Skip to search formSkip to main contentSkip to account menu

Anzatax

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE Low water solubility, high systemic toxicity and insignificant cellular uptake have limited efficient clinical… 
2016
2016
Aerosolized chemotherapeutics leads to higher, localized and continuous concentrations of active agents in lung tissue with lower… 
2015
2015
A simple, rapid, and sensitive reversed-phase HPLC method was developed and validated for determination of paclitaxel (PTX) in… 
2014
2014
Abstract A water-insoluble anti-tumor agent, paclitaxel (PTX) was successfully incorporated into novel-targeted polymeric… 
2008
2008
Objective:To observe the efficacy,tolerance and adverse effect of anzatax and cisplatin combined chemotherapy in the treatment of… 
2001
2001
BACKGROUND Paclitaxel is an active agent in the treatment of breast, ovarian, lung and head and neck cancers. In previous phase I… 
Highly Cited
1998
Highly Cited
1998
BACKGROUND Despite its moderate anti-tumour activity in head and neck cancers there have been no reports on the activity of… 
1997
1997
To determine the efficacy and safety of paclitaxel given as a three‐hour infusion in patients with metastatic breast cancer which…